• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化用于精神病研究的谷氨酸能激发模型,使用S+ -氯胺酮在健康志愿者中诱发拟精神病症状。

Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.

作者信息

Kleinloog Daniël, Uit den Boogaard Anna, Dahan Albert, Mooren René, Klaassen Erica, Stevens Jasper, Freijer Jan, van Gerven Joop

机构信息

Centre for Human Drug Research, Leiden, The Netherlands

Centre for Human Drug Research, Leiden, The Netherlands.

出版信息

J Psychopharmacol. 2015 Apr;29(4):401-13. doi: 10.1177/0269881115570082. Epub 2015 Feb 17.

DOI:10.1177/0269881115570082
PMID:25693889
Abstract

The psychomimetic effects that occur after acute administration of ketamine can constitute a model of psychosis and antipsychotic drug action. However, the optimal dose/concentration has not been established and there is a large variety in outcome measures. In this study, 36 healthy volunteers (21 males and 15 females) received infusions of S(+)-ketamine or placebo to achieve pseudo-steady state concentrations of 180 and 360 ng/mL during two hours. The target of 360 ng/mL induced increasingly more intensive effects than expected, and the targets were subsequently reduced to 120 and 240 ng/mL, which were considered tolerable. There was a clear, concentration-dependent psychomimetic effect as shown on all subscales of the positive and negative syndrome scale (e.g. positive subscale +43.7%, 95%CI 34.4-53.7%, p < 0.0001 for 120 ng/mL and +70.5%, 95%CI 59.0-82.8%, p < 0.0001 for 240 ng/mL) and different visual analogue scales. The startle reflex was inhibited (prepulse inhibition) by both main target concentrations to a similar extent, suggesting a maximum effect. Ketamine was found to constitute a robust model for induction of psychomimetic symptoms and the optimal concentration range for a drug interaction study would be between 100 and 200 ng/mL.

摘要

氯胺酮急性给药后出现的拟精神病效应可构成一种精神病和抗精神病药物作用的模型。然而,最佳剂量/浓度尚未确定,且结果测量存在很大差异。在本研究中,36名健康志愿者(21名男性和15名女性)接受了S(+)-氯胺酮或安慰剂输注,以在两小时内达到180和360 ng/mL的伪稳态浓度。360 ng/mL的目标浓度诱导的效应比预期更强烈,随后目标浓度降至120和240 ng/mL,这被认为是可耐受的。在阳性和阴性症状量表的所有子量表上均显示出明显的浓度依赖性拟精神病效应(例如,阳性子量表在120 ng/mL时为+43.7%,95%CI 34.4-53.7%,p < 0.0001;在240 ng/mL时为+70.5%,95%CI 59.0-82.8%,p < 0.0001)以及不同的视觉模拟量表。两种主要目标浓度对惊跳反射(前脉冲抑制)的抑制程度相似,表明达到了最大效应。发现氯胺酮是诱导拟精神病症状的可靠模型,药物相互作用研究的最佳浓度范围为100至200 ng/mL。

相似文献

1
Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.优化用于精神病研究的谷氨酸能激发模型,使用S+ -氯胺酮在健康志愿者中诱发拟精神病症状。
J Psychopharmacol. 2015 Apr;29(4):401-13. doi: 10.1177/0269881115570082. Epub 2015 Feb 17.
2
Effects of ketamine in normal and schizophrenic volunteers.氯胺酮对正常和精神分裂症志愿者的影响。
Neuropsychopharmacology. 2001 Oct;25(4):455-67. doi: 10.1016/S0893-133X(01)00243-3.
3
Low dose ketamine increases prepulse inhibition in healthy men.低剂量氯胺酮可增强健康男性的前脉冲抑制。
Neuropharmacology. 2003 May;44(6):729-37. doi: 10.1016/s0028-3908(03)00073-x.
4
Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.氯胺酮对被动听觉感觉门控范式中通过脑磁图/脑电图评估的中枢神经系统反应的影响:一项模拟人类精神病某些症状的尝试。
J Psychopharmacol. 2007 May;21(3):321-37. doi: 10.1177/0269881107077768.
5
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.(S)-氯胺酮和N,N-二甲基色胺(DMT)的心理效应:一项在健康志愿者中进行的双盲交叉研究。
Pharmacopsychiatry. 2005 Nov;38(6):301-11. doi: 10.1055/s-2005-916185.
6
Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.在人类精神分裂症的S-氯胺酮和N,N-二甲基色胺(DMT)模型中,惊吓反射的前脉冲抑制及其注意力调节。
J Psychopharmacol. 2007 May;21(3):312-20. doi: 10.1177/0269881107077734.
7
The effect of ketamine on configural facial processing.氯胺酮对构型面部加工的影响。
J Clin Psychopharmacol. 2015 Apr;35(2):188-91. doi: 10.1097/JCP.0000000000000278.
8
The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects.低剂量氯胺酮对健康人类受试者感觉门控、神经内分泌分泌及行为的影响。
Psychopharmacology (Berl). 1998 Jun;137(3):271-81. doi: 10.1007/s002130050620.
9
Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.人类5-羟色胺2A激动剂和N-甲基-D-天冬氨酸拮抗剂精神病模型中的返回抑制。
Neuropsychopharmacology. 2006 Feb;31(2):431-41. doi: 10.1038/sj.npp.1300882.
10
Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.氯胺酮诱导的N-甲基-D-天冬氨酸受体功能减退作为记忆障碍和精神病的模型。
Neuropsychopharmacology. 1999 Feb;20(2):106-18. doi: 10.1016/S0893-133X(98)00067-0.

引用本文的文献

1
Ketamine effects on resting state functional brain connectivity in major depressive disorder patients: a hypothesis-driven analysis based on a network model of depression.氯胺酮对重度抑郁症患者静息态脑功能连接的影响:基于抑郁症网络模型的假设驱动分析。
Front Neurosci. 2025 Feb 3;19:1531375. doi: 10.3389/fnins.2025.1531375. eCollection 2025.
2
Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers.(S)-氯胺酮在健康志愿者中的母体-代谢物群体药代动力学模型的预测性能。
Eur J Clin Pharmacol. 2021 Aug;77(8):1181-1192. doi: 10.1007/s00228-021-03104-1. Epub 2021 Feb 11.
3
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.
氯胺酮与精神症状的关联及其对治疗的影响和对精神分裂症的理解:系统评价和荟萃分析。
JAMA Netw Open. 2020 May 1;3(5):e204693. doi: 10.1001/jamanetworkopen.2020.4693.
4
Mis-anaesthetized society: expectancies and recreational use of ketamine in Taiwan.麻醉不当的社会:台湾民众对氯胺酮的期望和娱乐性使用。
BMC Public Health. 2019 Oct 17;19(1):1307. doi: 10.1186/s12889-019-7616-1.
5
Long-lasting effects of repeated ketamine administration in adult and adolescent rats.反复给予氯胺酮对成年和青少年大鼠的长期影响。
Behav Brain Res. 2019 Sep 2;369:111928. doi: 10.1016/j.bbr.2019.111928. Epub 2019 Apr 26.
6
Subanesthetic Dose Ketamine in Posttraumatic Stress Disorder: A Role for Reconsolidation During Trauma-Focused Psychotherapy?亚麻醉剂量氯胺酮在创伤后应激障碍中的作用:在以创伤为重点的心理治疗过程中重新巩固是否发挥作用?
Curr Top Behav Neurosci. 2018;38:137-162. doi: 10.1007/7854_2017_34.
7
Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers.在健康志愿者中,静息状态下及静脉注射S-氯胺酮后即刻,前扣带回皮质中的谷氨酸水平与静息脑血流量相关。
Front Psychiatry. 2018 Feb 6;9:22. doi: 10.3389/fpsyt.2018.00022. eCollection 2018.
8
Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.GABA-B 受体正向变构调节剂对氯胺酮诱导的精神分裂症相关行为和自由活动大鼠海马电活动的影响。
Psychopharmacology (Berl). 2017 Oct;234(20):3129-3142. doi: 10.1007/s00213-017-4705-7. Epub 2017 Jul 29.
9
Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.青少年与成年人在苯环己哌啶(PCP)和氯胺酮急性效应以及间歇性给药后的致敏作用方面的差异。
Pharmacol Biochem Behav. 2017 Jun;157:24-34. doi: 10.1016/j.pbb.2017.04.007. Epub 2017 Apr 22.
10
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.氯胺酮:麻醉与疼痛治疗中临床药代动力学与药效学综述
Clin Pharmacokinet. 2016 Sep;55(9):1059-77. doi: 10.1007/s40262-016-0383-6.